WHO ICTRP trial
Establishment and Validation of Organ Support and Severe Complication Prevention…
ChiCTR2600116041 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600116041 |
|---|---|
| Public title | Establishment and Validation of Organ Support and Severe Complication Prevention Strategies for Adverse Reactions in Tumor Immunotherapy Based on Multi-Omics Approaches |
| Scientific title | Establishment and Validation of Organ Support and Severe Complication Prevention Strategies for Adverse Reactions in Tumor Immunotherapy Based on Multi-Omics Approaches |
| Primary sponsor | Peking Union Medical College Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | immune-related adverse events |
| Interventions | Control group:Based on clinical evaluation, physical examination, laboratory tests, and imaging findings, clinicians determine whether the etiology of a patients organ dysfunction is immune-related adverse events (irAEs), infection, or a… |
| Registration date | Jan 5, 2026 |
| Target size | Control group:280;Intervention Group:280 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: